Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study offers smokers with HIV free nicotine alternatives to kick the habit

NCT ID NCT06789692

Disease control Sponsor: University Hospital, Basel, Switzerland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether offering a choice of e-cigarettes, nicotine pouches, or nicotine patches helps people with HIV stop smoking tobacco. About 972 participants in Switzerland will receive their preferred product free for 6 months, plus standard care. The main goal is to see if more people report not smoking for 7 days at the 6-month mark.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
tobacco smoking substitution products (e-cigarettes, nicotine pouches, nicotine patches)
What this could lead to
If successful, this could provide an effective way to help people with HIV quit smoking, reducing their risk of smoking-related diseases.
What could go wrong
This is a pragmatic trial without a placebo, so results may be influenced by participant expectations. The study relies on self-reported smoking status, which may not be fully accurate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 972 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Signed informed consent for the data collection and participation in the SHCS (Cohort consent). * Signed informed consent to be randomized to future interventions (Randomization consent). * Age 18 years or older. * Smoked one or more tobacco cigarettes per day (smoking status = yes) at the time of enrolment. Exclusion Criteria: * Currently using e-cigarettes or nicotine pouches or nicotine patches. * Pregnant women.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

HIV infectious disease nicotine dependence Smoking Tobacco Smoking Vaping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV Smoking

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cantonal Hospital Aarau

    RECRUITING

    Aarau, 5001, Switzerland

  • Cantonal Hospital St. Gallen

    RECRUITING

    Sankt Gallen, Canton of St. Gallen, 9007, Switzerland

  • Inselspital Bern

    RECRUITING

    Bern, Canton of Bern, 3010, Switzerland

  • University Hospital Basel

    COMPLETED

    Basel, Basel, 4031, Switzerland

  • University Hospital Geneva

    RECRUITING

    Geneva, Switzerland

  • University Hospital Lausanne

    RECRUITING

    Lausanne, Canton of Vaud, 1011, Switzerland

  • University Hospital Zurich

    RECRUITING

    Zurich, Canton of Zurich, 8006, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.